REMI

REMEDENT, INC.
CAPPED RATING

Remedent, Inc. engags in the research, development, and manufacturing of oral care and cosmetic dentistry products. Its products include river 8, prefab veneer, and condor. The company was founded on September 30, 1996 and is headquartered in Ghent, Belgium.

REMEDENT, INC. (REMI) is rated C (2.3/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Profitability (B-); its weakest is Revisions (D+). The rating has held at C for 304 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
C+
Factor Score 2.5 / 5.0
Growth
C
Factor Score 2.3 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
C-
Factor Score 1.9 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA N/A
Rev Growth YoY 4.8%
Gross Margin 61.9%
Price Return 3M 0.0%
Price Return 12M -92.2%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales N/A
ROE 2.0%

Historical Factor Score Progression

Held C for 304 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.5) C (2.3) B- (3.0) C- (1.9) D+ (1.5) C (2.3)
2020-12-31 C+ (2.5) C (2.2) B- (3.1) C- (1.9) D (1.5) C (2.2)
2020-09-30 C+ (2.5) C+ (2.5) B- (3.1) C- (2.0) D (1.4) C (2.3)